Classical membrane progesterone receptors in murine mammary carcinomas: Agonistic effects of progestins and RU-486 mediating rapid non-genomic effects

In this article, we demonstrate the expression of functional progesterone binding sites at the cell membrane in murine mammary carcinomas that are stimulated by progestins and inhibited by antiprogestins. Using confocal immunofluorescence, ligand binding and cell compartment-specific western blots,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Bottino, María Cecilia, Giulianelli, Sebastián Jesús, Mondillo, Carolina, Gorostiaga, María A., Pignataro, Omar Pedro, Calvo, Juan Carlos, Lüthy, Isabel Alicia, Lanari, Claudia Lee Malvina
Publicado: 2011
Materias:
DNA
Acceso en línea:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_01676806_v126_n3_p621_Bottino
http://hdl.handle.net/20.500.12110/paper_01676806_v126_n3_p621_Bottino
Aporte de:
id paper:paper_01676806_v126_n3_p621_Bottino
record_format dspace
spelling paper:paper_01676806_v126_n3_p621_Bottino2023-06-08T15:16:41Z Classical membrane progesterone receptors in murine mammary carcinomas: Agonistic effects of progestins and RU-486 mediating rapid non-genomic effects Bottino, María Cecilia Giulianelli, Sebastián Jesús Mondillo, Carolina Gorostiaga, María A. Pignataro, Omar Pedro Calvo, Juan Carlos Lüthy, Isabel Alicia Lanari, Claudia Lee Malvina Antiprogestins Breast cancer treatment Mammary carcinomas Membrane progesterone receptors Non-genomic effects Progesterone receptor isoforms: Membrane-initiated steroid signaling Progestins 2 (2 amino 3 methoxyphenyl)chromone cyclin D1 DNA hydroxytamoxifen medroxyprogesterone acetate mifepristone mitogen activated protein kinase progesterone receptor thromboplastin animal experiment animal model animal tissue article binding site breast carcinoma cancer growth cancer regression cell membrane cell proliferation concentration response controlled study drug dose comparison drug effect enzyme activation female human human cell immunofluorescence test in vitro study in vivo study ligand binding mouse nonhuman nucleotide sequence priority journal protein DNA binding protein expression Western blotting Animals Female Gene Expression Regulation, Neoplastic Mammary Neoplasms, Animal Medroxyprogesterone Acetate Mice Mice, Inbred BALB C Microscopy, Confocal Microscopy, Fluorescence Mifepristone Neoplasm Transplantation Progestins Receptors, Progesterone Steroids In this article, we demonstrate the expression of functional progesterone binding sites at the cell membrane in murine mammary carcinomas that are stimulated by progestins and inhibited by antiprogestins. Using confocal immunofluorescence, ligand binding and cell compartment-specific western blots, we were able to identify the presence of the classical progesterone receptors. Medrox-yprogesterone acetate (MPA) and RU-486 (1 × 10-11 and 1 × 10-8 M) behaved as agonists activating extracellular signal-regulated kinases (ERKs) and progestin-regulated proteins, except for Cyclin D1 and Tissue factor which failed to increase with 1 × 10 -8 M RU-486, an experimental condition that allows PR to bind DNA. These results predicted a full agonist effect at low concentrations of RU-486. Accordingly, at concentrations lower than 1 × 10-11 M, RU-486 increased cell proliferation in vitro. This effect was abolished by incubation with the ERK kinase inhibitor PD 98059 or by OH-tamoxifen. In vivo, at a daily dose of 1.2 μg/kg body weight RU-486 increased tumor growth, whereas at 12 mg/kg induces tumor regression. Our results indicate that low concentrations of MPA and RU-486 induce similar agonistic non-genomic effects, whereas RU-486 at higher concentrations may inhibit cell proliferation by genomic-induced effects. This suggests that RU-486 should be therapeutically administered at doses high enough to guarantee its genomic inhibitory effect. © Springer Science+Business Media, LLC. 2010. Fil:Bottino, M.C. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Giulianelli, S. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Mondillo, C. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Gorostiaga, M.A. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Pignataro, O.P. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Calvo, J.C. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Lüthy, I.A. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Lanari, C. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. 2011 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_01676806_v126_n3_p621_Bottino http://hdl.handle.net/20.500.12110/paper_01676806_v126_n3_p621_Bottino
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Antiprogestins
Breast cancer treatment
Mammary carcinomas
Membrane progesterone receptors
Non-genomic effects
Progesterone receptor isoforms: Membrane-initiated steroid signaling
Progestins
2 (2 amino 3 methoxyphenyl)chromone
cyclin D1
DNA
hydroxytamoxifen
medroxyprogesterone acetate
mifepristone
mitogen activated protein kinase
progesterone receptor
thromboplastin
animal experiment
animal model
animal tissue
article
binding site
breast carcinoma
cancer growth
cancer regression
cell membrane
cell proliferation
concentration response
controlled study
drug dose comparison
drug effect
enzyme activation
female
human
human cell
immunofluorescence test
in vitro study
in vivo study
ligand binding
mouse
nonhuman
nucleotide sequence
priority journal
protein DNA binding
protein expression
Western blotting
Animals
Female
Gene Expression Regulation, Neoplastic
Mammary Neoplasms, Animal
Medroxyprogesterone Acetate
Mice
Mice, Inbred BALB C
Microscopy, Confocal
Microscopy, Fluorescence
Mifepristone
Neoplasm Transplantation
Progestins
Receptors, Progesterone
Steroids
spellingShingle Antiprogestins
Breast cancer treatment
Mammary carcinomas
Membrane progesterone receptors
Non-genomic effects
Progesterone receptor isoforms: Membrane-initiated steroid signaling
Progestins
2 (2 amino 3 methoxyphenyl)chromone
cyclin D1
DNA
hydroxytamoxifen
medroxyprogesterone acetate
mifepristone
mitogen activated protein kinase
progesterone receptor
thromboplastin
animal experiment
animal model
animal tissue
article
binding site
breast carcinoma
cancer growth
cancer regression
cell membrane
cell proliferation
concentration response
controlled study
drug dose comparison
drug effect
enzyme activation
female
human
human cell
immunofluorescence test
in vitro study
in vivo study
ligand binding
mouse
nonhuman
nucleotide sequence
priority journal
protein DNA binding
protein expression
Western blotting
Animals
Female
Gene Expression Regulation, Neoplastic
Mammary Neoplasms, Animal
Medroxyprogesterone Acetate
Mice
Mice, Inbred BALB C
Microscopy, Confocal
Microscopy, Fluorescence
Mifepristone
Neoplasm Transplantation
Progestins
Receptors, Progesterone
Steroids
Bottino, María Cecilia
Giulianelli, Sebastián Jesús
Mondillo, Carolina
Gorostiaga, María A.
Pignataro, Omar Pedro
Calvo, Juan Carlos
Lüthy, Isabel Alicia
Lanari, Claudia Lee Malvina
Classical membrane progesterone receptors in murine mammary carcinomas: Agonistic effects of progestins and RU-486 mediating rapid non-genomic effects
topic_facet Antiprogestins
Breast cancer treatment
Mammary carcinomas
Membrane progesterone receptors
Non-genomic effects
Progesterone receptor isoforms: Membrane-initiated steroid signaling
Progestins
2 (2 amino 3 methoxyphenyl)chromone
cyclin D1
DNA
hydroxytamoxifen
medroxyprogesterone acetate
mifepristone
mitogen activated protein kinase
progesterone receptor
thromboplastin
animal experiment
animal model
animal tissue
article
binding site
breast carcinoma
cancer growth
cancer regression
cell membrane
cell proliferation
concentration response
controlled study
drug dose comparison
drug effect
enzyme activation
female
human
human cell
immunofluorescence test
in vitro study
in vivo study
ligand binding
mouse
nonhuman
nucleotide sequence
priority journal
protein DNA binding
protein expression
Western blotting
Animals
Female
Gene Expression Regulation, Neoplastic
Mammary Neoplasms, Animal
Medroxyprogesterone Acetate
Mice
Mice, Inbred BALB C
Microscopy, Confocal
Microscopy, Fluorescence
Mifepristone
Neoplasm Transplantation
Progestins
Receptors, Progesterone
Steroids
description In this article, we demonstrate the expression of functional progesterone binding sites at the cell membrane in murine mammary carcinomas that are stimulated by progestins and inhibited by antiprogestins. Using confocal immunofluorescence, ligand binding and cell compartment-specific western blots, we were able to identify the presence of the classical progesterone receptors. Medrox-yprogesterone acetate (MPA) and RU-486 (1 × 10-11 and 1 × 10-8 M) behaved as agonists activating extracellular signal-regulated kinases (ERKs) and progestin-regulated proteins, except for Cyclin D1 and Tissue factor which failed to increase with 1 × 10 -8 M RU-486, an experimental condition that allows PR to bind DNA. These results predicted a full agonist effect at low concentrations of RU-486. Accordingly, at concentrations lower than 1 × 10-11 M, RU-486 increased cell proliferation in vitro. This effect was abolished by incubation with the ERK kinase inhibitor PD 98059 or by OH-tamoxifen. In vivo, at a daily dose of 1.2 μg/kg body weight RU-486 increased tumor growth, whereas at 12 mg/kg induces tumor regression. Our results indicate that low concentrations of MPA and RU-486 induce similar agonistic non-genomic effects, whereas RU-486 at higher concentrations may inhibit cell proliferation by genomic-induced effects. This suggests that RU-486 should be therapeutically administered at doses high enough to guarantee its genomic inhibitory effect. © Springer Science+Business Media, LLC. 2010.
author Bottino, María Cecilia
Giulianelli, Sebastián Jesús
Mondillo, Carolina
Gorostiaga, María A.
Pignataro, Omar Pedro
Calvo, Juan Carlos
Lüthy, Isabel Alicia
Lanari, Claudia Lee Malvina
author_facet Bottino, María Cecilia
Giulianelli, Sebastián Jesús
Mondillo, Carolina
Gorostiaga, María A.
Pignataro, Omar Pedro
Calvo, Juan Carlos
Lüthy, Isabel Alicia
Lanari, Claudia Lee Malvina
author_sort Bottino, María Cecilia
title Classical membrane progesterone receptors in murine mammary carcinomas: Agonistic effects of progestins and RU-486 mediating rapid non-genomic effects
title_short Classical membrane progesterone receptors in murine mammary carcinomas: Agonistic effects of progestins and RU-486 mediating rapid non-genomic effects
title_full Classical membrane progesterone receptors in murine mammary carcinomas: Agonistic effects of progestins and RU-486 mediating rapid non-genomic effects
title_fullStr Classical membrane progesterone receptors in murine mammary carcinomas: Agonistic effects of progestins and RU-486 mediating rapid non-genomic effects
title_full_unstemmed Classical membrane progesterone receptors in murine mammary carcinomas: Agonistic effects of progestins and RU-486 mediating rapid non-genomic effects
title_sort classical membrane progesterone receptors in murine mammary carcinomas: agonistic effects of progestins and ru-486 mediating rapid non-genomic effects
publishDate 2011
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_01676806_v126_n3_p621_Bottino
http://hdl.handle.net/20.500.12110/paper_01676806_v126_n3_p621_Bottino
work_keys_str_mv AT bottinomariacecilia classicalmembraneprogesteronereceptorsinmurinemammarycarcinomasagonisticeffectsofprogestinsandru486mediatingrapidnongenomiceffects
AT giulianellisebastianjesus classicalmembraneprogesteronereceptorsinmurinemammarycarcinomasagonisticeffectsofprogestinsandru486mediatingrapidnongenomiceffects
AT mondillocarolina classicalmembraneprogesteronereceptorsinmurinemammarycarcinomasagonisticeffectsofprogestinsandru486mediatingrapidnongenomiceffects
AT gorostiagamariaa classicalmembraneprogesteronereceptorsinmurinemammarycarcinomasagonisticeffectsofprogestinsandru486mediatingrapidnongenomiceffects
AT pignataroomarpedro classicalmembraneprogesteronereceptorsinmurinemammarycarcinomasagonisticeffectsofprogestinsandru486mediatingrapidnongenomiceffects
AT calvojuancarlos classicalmembraneprogesteronereceptorsinmurinemammarycarcinomasagonisticeffectsofprogestinsandru486mediatingrapidnongenomiceffects
AT luthyisabelalicia classicalmembraneprogesteronereceptorsinmurinemammarycarcinomasagonisticeffectsofprogestinsandru486mediatingrapidnongenomiceffects
AT lanariclaudialeemalvina classicalmembraneprogesteronereceptorsinmurinemammarycarcinomasagonisticeffectsofprogestinsandru486mediatingrapidnongenomiceffects
_version_ 1768545046170173440